anti-microbials Flashcards

anti-viral drugs: summarise the mechanisms of action of anti-viral drugs used in the treatment of HIV, hepatitis, herpes and influenza

1
Q

when does hep B and C require treatment

A

when chronic infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

anti-viral for hep B and how it works

A

tenofovir (nucleotide analogue that blocks replication of DNA; given with peginterferon a)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe how tenofovir manages hep B

A

contains hep B into chronically managed disease, but doesn’t cure it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

2 anti-virals for hep C and how they work

A

ribavirin and peginterferon a (nucleoside (purine) analogue preventing viral RNA synthesis), boceprevir (protease inhibitor)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe how hep C is managed

A

many drugs target many different viral proteins (e.g. p7, NS3/4A, NS5A, NS5B), and aim is to cure hep C (must have vaccine to eradicate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what do drugs and duration of treatment for hep C depend on

A

genotype, viral load, past treatment experience, degree of liver damage, ability to tolerate prescribed treatment, need for liver transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

2 anti-virals which prevent HIV attachment and entry

A

enfuvirtide, maraviroc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

HIV entry inhibitors: mechanism of action of enfuvirtide

A

binds to HIV GP41 transmembrane receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HIV entry inhibitors: mechanism of action of maraviroc

A

block CCR5 chemokine receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe how some people are long-term progressors of HIV

A

delta 32 mutation meaning don’t produce CCR5 receptor, so HIV invades somewhat but not to a huge extent, so takes a very long time to progress disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HIV replication inhibitors: how are nucleoside reverse transcriptase inhibitors, nucleotide reverse transcriptase inhibitors and non-nucleoside reverse transcriptase inhibitors activated (compared to each other), and where do they bind

A

nucleoside RT inhibitors: 3 step phosphorylation process (binds to active sire of enzyme); nucleotide RT inhibitors: fewer phosphorylation steps (binds to active sire of enzyme); non-nucleoside RT inhibitors (no phosphorylation as not incorporated into viral DNA - binds to allosteric site on reverse transcriptase)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HIV replication inhibitors: example of nucleoside RT inhibitor

A

zidovudine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HIV replication inhibitors: example of nucleotide RT inhibitor

A

tenofovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

HIV replication inhibitors: example of non-nucleoside RT inhibitor

A

efavirenz

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

HIV integrase inhibitors: example of HIV integrase inhibitor which prevents integration of viral DNA into host

A

raltegravir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

HIV protease inhibitors: 1st generation protease inhibitor which prevents cleavage of Gag for assembly of HIV proteins

A

saquinavir

17
Q

HIV protease inhibitors: why is low dose ritonavir co-administered with saquinavir

A

reduces protease inhibitor metabolism, so acts as “booster”

18
Q

treatment for Herpes simplex virus

A

nucleoside analogues e.g. aciclovir (therefore prevent DNA replication)

19
Q

treatment for influenza

A

neuraminidase inhibitor e.g. oseltamivir (inhibits neuraminidase protein on influenza envelope)

20
Q

what do nucleoside analogues treat

A

HIV, hepatitis, herpes simplex

21
Q

what do viral integrase target

A

HIV integrase

22
Q

what do proteases treat

A

HIV, hep C